Different efficacy of soluble CD14 treatment in high- and low-dose LPS models.
about
Role of CD14 in a mouse model of acute lung inflammation induced by different lipopolysaccharide chemotypes.Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studiesLipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation.Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coliReceptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Lipopolysaccharide induced synthesis of CD14 proteins and its gene expression in hepatocytes during endotoxemiaCD14 is associated with biliary stricture formation.Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins.Targeting of key pathogenic factors from gram-positive bacteria by the soluble ectodomain of the scavenger-like lymphocyte receptor CD6.CD14 is an essential mediator of LPS-induced airway disease.
P2860
Q33564362-2E421903-8361-4631-A5D9-D52AC4734647Q33767761-6AFED865-F3DE-4A9C-A8D3-8220A2232242Q34744890-F0EA7974-9625-4EDB-BFA1-F055881CC3F9Q35105577-771A8E68-B0AD-4202-AA5E-35BAB3AAAEC6Q35176262-31140F12-2734-4C2D-B7CF-BCBF59CDD3F1Q36309059-C94466AE-0C97-41D7-8202-4910FD67FF77Q38896152-0E35F584-25DB-434A-ADA0-35D0E303AF98Q39946859-80D2A538-CFA8-4CC6-A14B-061FF99375E5Q42239720-8B540198-0D05-43C4-BF01-D56F4717CD09Q53574724-59ADD7C6-7DAD-420C-AD2E-0FD9816F57B0
P2860
Different efficacy of soluble CD14 treatment in high- and low-dose LPS models.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Different efficacy of soluble CD14 treatment in high- and low-dose LPS models.
@en
Different efficacy of soluble CD14 treatment in high- and low-dose LPS models.
@nl
type
label
Different efficacy of soluble CD14 treatment in high- and low-dose LPS models.
@en
Different efficacy of soluble CD14 treatment in high- and low-dose LPS models.
@nl
prefLabel
Different efficacy of soluble CD14 treatment in high- and low-dose LPS models.
@en
Different efficacy of soluble CD14 treatment in high- and low-dose LPS models.
@nl
P2093
P2860
P1476
Different efficacy of soluble CD14 treatment in high- and low-dose LPS models.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2362.1998.00264.X
P577
1998-03-01T00:00:00Z